Approval · Notice of Compliance 5346 · 2003
RESCRIPTOR: Notice of Compliance 5346
Issued July 22, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5346
- Date
- July 22, 2003
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replaces the notice of compliance with conditions issued on april 25, 2000
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RESCRIPTOR | Not yet assigned | — |
Medicinal ingredients
- DELAVIRDINE MESYLATE 100 MG per TAB